Literature DB >> 23123626

Salinomycin, a polyether ionophoric antibiotic, inhibits adipogenesis.

Maria Szkudlarek-Mikho1, Rudel A Saunders, Sook Fan Yap, Yun Fong Ngeow, Khew-Voon Chin.   

Abstract

The polyether ionophoric antibiotics including monensin, salinomycin, and narasin, are widely used in veterinary medicine and as food additives and growth promoters in animal husbandry including poultry farming. Their effects on human health, however, are not fully understood. Recent studies showed that salinomycin is a cancer stem cell inhibitor. Since poultry consumption has risen sharply in the last three decades, we asked whether the consumption of meat tainted with growth promoting antibiotics might have effects on adipose cells. We showed in this report that the ionophoric antibiotics inhibit the differentiation of preadipocytes into adipocytes. The block of differentiation is not due to the induction of apoptosis nor the inhibition of cell proliferation. In addition, salinomycin also suppresses the transcriptional activity of the CCAAT/enhancer binding proteins and the peroxisome proliferator-activated receptor γ. These results suggest that the ionophoric antibiotics can be exploited as novel anti-obesity therapeutics and as pharmacological probes for the study of adipose biology. Further, the pharmacological effects of salinomycin could be a harbinger of its toxicity on the adipose tissue and other susceptible target cells in cancer therapy.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23123626      PMCID: PMC3517190          DOI: 10.1016/j.bbrc.2012.10.080

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  33 in total

Review 1.  Structure, conformation, and mechanism in the membrane transport of alkali metal ions by ionophoric antibiotics.

Authors:  Frank G Riddell
Journal:  Chirality       Date:  2002 Feb-Mar       Impact factor: 2.437

2.  Hyperphagia and obesity in Na,K-ATPase alpha2 subunit-defective mice.

Authors:  Kiyoshi Kawakami; Tatsushi Onaka; Michiko Iwase; Ikuo Homma; Keiko Ikeda
Journal:  Obes Res       Date:  2005-10

3.  Toxicity of maduramicin.

Authors:  N Sharma; A Bhalla; S Varma; S Jain; S Singh
Journal:  Emerg Med J       Date:  2005-12       Impact factor: 2.740

Review 4.  Na+, K+ -ATPase: an indispensable ion pumping-signaling mechanism across mammalian cell membranes.

Authors:  A Ariel Jaitovich; Alejandro M Bertorello
Journal:  Semin Nephrol       Date:  2006-09       Impact factor: 5.299

5.  Comparison of the oral bioavailability and tissue disposition of monensin and salinomycin in chickens and turkeys.

Authors:  J Henri; R Maurice; G Postollec; E Dubreil-Cheneau; B Roudaut; M Laurentie; P Sanders
Journal:  J Vet Pharmacol Ther       Date:  2011-05-26       Impact factor: 1.786

6.  Rhabdomyolysis, acute renal failure, and death after monensin ingestion.

Authors:  C Caldeira; W S Neves; P M Cury; P Serrano; M A Baptista; E A Burdmann
Journal:  Am J Kidney Dis       Date:  2001-11       Impact factor: 8.860

7.  Incidence of residues of nine anticoccidials in eggs.

Authors:  L Mortier; A-C Huet; C Charlier; E Daeseleire; P Delahaut; C Van Peteghem
Journal:  Food Addit Contam       Date:  2005-11

8.  Salinomycin induces apoptosis and overcomes apoptosis resistance in human cancer cells.

Authors:  Dominik Fuchs; Andreas Heinold; Gerhard Opelz; Volker Daniel; Cord Naujokat
Journal:  Biochem Biophys Res Commun       Date:  2009-10-14       Impact factor: 3.575

Review 9.  Adipokine dysregulation, adipose tissue inflammation and metabolic syndrome.

Authors:  E Maury; S M Brichard
Journal:  Mol Cell Endocrinol       Date:  2009-08-12       Impact factor: 4.102

10.  Application of Nile red, a fluorescent hydrophobic probe, for the detection of neutral lipid deposits in tissue sections: comparison with oil red O.

Authors:  S D Fowler; P Greenspan
Journal:  J Histochem Cytochem       Date:  1985-08       Impact factor: 2.479

View more
  5 in total

1.  HDAC inhibitors enhance the lethality of low dose salinomycin in parental and stem-like GBM cells.

Authors:  Laurence Booth; Jane L Roberts; Adam Conley; Nichola Cruickshanks; Thomas Ridder; Steven Grant; Andrew Poklepovic; Paul Dent
Journal:  Cancer Biol Ther       Date:  2013-12-18       Impact factor: 4.742

2.  Salinomycin inhibits hepatocellular carcinoma cell invasion and migration through JNK/JunD pathway-mediated MMP9 expression.

Authors:  Ling Xu; Ting Wang; Wen-Ying Meng; Jue Wei; Jia-Li Ma; Min Shi; Yu-Gang Wang
Journal:  Oncol Rep       Date:  2014-12-18       Impact factor: 3.906

Review 3.  Salinomycin as a potent anticancer stem cell agent: State of the art and future directions.

Authors:  Dan Qi; Yunyi Liu; Juan Li; Jason H Huang; Xiaoxiao Hu; Erxi Wu
Journal:  Med Res Rev       Date:  2021-11-16       Impact factor: 12.388

4.  Chronic exposure of low dose salinomycin inhibits MSC migration capability in vitro.

Authors:  Agmal Scherzad; Stephan Hackenberg; Katrin Froelich; Kristen Rak; Rudolf Hagen; Johannes Taeger; Maximillian Bregenzer; Norbert Kleinsasser
Journal:  Biomed Rep       Date:  2016-01-14

5.  The Presence or Absence of Intestinal Microbiota Affects Lipid Deposition and Related Genes Expression in Zebrafish (Danio rerio).

Authors:  Yi Sheng; Hui Ren; Samwel M Limbu; Yuhong Sun; Fang Qiao; Wanying Zhai; Zhen-Yu Du; Meiling Zhang
Journal:  Front Microbiol       Date:  2018-05-29       Impact factor: 5.640

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.